Filtered By:
Source: bizjournals.com Health Care:Pharmaceuticals headlines
Condition: Tinnitus
This page shows you your search results in order of date.
Order by Relevance | Date
Total 1 results found since Jan 2013.
MicroTransponder completes $3.4M in funding, gets key patent
Dallas-based MicroTransponder Inc., a privately-held medical device company, has completed a $3.39 million funding round this summer, which will enable the company to accelerate development of its wireless pain platform.
The funding will allow MicroTransponder to complete three additional clinical trials using its neurostimulation system to treat both stroke patients and tinnitus patients, Jordan Curnes, co-founder, president and chief operating officer, told me.
Tinnitus is the medical term for…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - August 30, 2013 Category: Pharmaceuticals Authors: Bill Hethcock Source Type: research
